The potential of gut-microbiota-targeted reprogramming interventions designed to prevent the onset and progression of cardiovascular diseases

SAN DIEGO — As its com­peti­tors cel­e­brate the land­mark ap­proval of two sick­le cell gene ther­a­pies, Ed­i­tas Med­i­cine de­tailed promis­ing ear­ly re­sults in a small

A New Jer­sey fed­er­al judge on Mon­day tossed cas­es brought by John­son & John­son and Bris­tol My­ers Squibb against the In­fla­tion Re­duc­tion Act, an­oth­er vic­to­ry

ACG aims to cut packaging and manufacturing emissions by 5.2% year-on-year in line with its SBTi goals Sustainability in the 21st century is an essential